P.482 Oral fluids as a medium for prevalence studies on viral hepatitis A, b and C

✍ Scribed by R. Vranckx

Book ID: 117770690
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 139 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(06)80655-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Seven-Year Experiences on Antiviral Trea

Seven-Year Experiences on Antiviral Treatment for Chronic Viral B and C Hepatitis in Hungary - A Nation-Wide Study

✍ Par, A.; Tornai, I.; Szalay, F. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Response-Guided Therapy as an Effective

Response-Guided Therapy as an Effective Strategy on Peginterferon Alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 2 and a High Viral Road

✍ Sato, Ken ;Hashizume, Hiroaki ;Yamazaki, Yuichi ;Horiguchi, Norio ;Kakizaki, Sat 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Case-control study on hepatitis C virus

Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol

✍ Alessandro Tagger; Francesco Donato; Maria L. Ribero; Roberta Chiesa; Giuseppe P 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 70 KB 👁 3 views

We performed a case-control study to evaluate the risk of hepatocellular carcinoma (HCC) for hepatitis C virus (HCV) infection. A total of 305 newly diagnosed HCC cases (80% males) and 610 subjects (81% males) unaffected by clinically evident hepatic disease admitted to the 2 main hospitals in Bresc

Prevalence and Clinical Relevance of Occ

Prevalence and Clinical Relevance of Occult Hepatitis B Virus Infection in Patients on the Waiting List for Kidney Transplantation

✍ P. Stratta; E. Bruschetta; R. Minisini; M.C. Barbè; C. Cornella; G. Tognarelli; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Commentary on “Identification of 23 new

Commentary on “Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.” Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS–Cancer Research UK GWAS–ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study

✍ Olumi, Aria F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB